Philadelphia, PA, October 28, 2016 – PolyAurum today announced it will present at the IMPACT 2016 Capital Conference on November 30. Hosted by Grant Thornton and Presented by the Philadelphia Alliance for Capital and Technologies (PACT), the IMPACT Capital Conference unites the private equity, venture capital, and entrepreneurial communities in the Mid-Atlantic region. For over 20 years, IMPACT has stimulated billions of dollars in venture funding and entrepreneurial success.
We are thrilled to have been selected from 165 applicants as one of the featured companies presenting at this very important investor conference, said Debra Travers, President and CEO of PolyAurum. The exposure that start-ups like PolyAurum get to investors and the coaching provided is invaluable. The likelihood of having your technology’s value proposition resonate with an investor is greatly increased when you get this many investors at one conference.
PolyAurum is a preclinical stage biotech startup spun out of the University of Pennsylvania to develop biodegradable gold nanoparticles for treating cancer. Of the 1.7 million Americans diagnosed with cancer every year, half of them get radiation therapy. But for certain locally advanced tumors there is a high rate of therapy failures which leads to disease progression and death for those patients. For example, the average survival for a patient with glioblastoma – a deadly form of brain cancer – is a little over a year post treatment. That’s because you can’t push the dose of radiation high enough to kill the tumor without significant damage to the healthy parts of the brain. Our biodegradable gold nanoparticles localize selectively in the tumor and amplify the effect of radiation therapy only in the tumor, allowing a radiation oncologist to more effectively destroy the cancer cells without increasing damage to healthy tissue. “In animal models of cancer, we’ve seen doubling of survival, and in some cases disappearance of the tumor when our gold nanoparticles are given with radiation therapy versus those given radiation therapy alone. Now we need to show that these results can be duplicated in human patients,” said Travers.
45 Entrepreneurial Companies total will pitch their innovations live in front of investors, professional advisors and key decision makers on November 30. During the pitching hours, the featured companies will receive direct feedback (aka: Direct IMPACT) with hopes to take home funding, gain experience and make lasting business connections. Additionally, each company will vie to enter the IMPACT Lion’s Den for a chance to receive funding in real time from a panel of accomplished investors. For more information on IMPACT 2016 Capital Conference, please visit www.phillyimpact.com.
History of IMPACT
The IMPACT Capital Conference has a long tradition of uniting key players from the private equity, venture capital, and entrepreneurial communities. This day-and-a-half event offers both sponsors and attendees access to emerging companies from the Mid-Atlantic region. As the oldest and most established venture conference in the Northeast, IMPACT draws more than 1,000 participants. It stands as the catalyst for billions of dollars in venture funding and entrepreneurial success in the region. www.phillyimpact.com
About Philadelphia Alliance for Capital and Technologies (PACT)
Philadelphia Alliance for Capital and Technologies (PACT)’s vision is to be the go-to resource for fast growing companies, and a driver of entrepreneurship and innovation in the Philadelphia region. PACT provides its members with valuable content and connections to capital, coaching, and customers that will accelerate their growth and success, and to collaborate with other organizations to drive innovation and entrepreneurship in the region. Visit www.philadelphiapact.com for more information.
For more information about PolyAurum, contact Debra Travers at firstname.lastname@example.org or visit our website at: https://www.polyaurum.com.